Bristol Myers Squibb

Bristol Myers Squibb

company0.0Global Dominance: 0.00%

Bristol Myers Squibb (BMS) is a multinational pharmaceutical company headquartered in New York City, renowned for its commitment to discovering, developing, and delivering innovative medicines to patients with serious diseases. With a strong emphasis on oncology, immunology, and cardiovascular health, BMS has made significant contributions to the treatment landscape, including breakthroughs in cancer therapies. The company has a robust pipeline of drugs and is dedicated to addressing unmet medical needs through its research and development efforts.

Power0
Reach0
Collect

Not in the pool (under ¢1).

Recent news mentions

Bristol Myers Squibb announced it will charge the same price for its schizophrenia drug in the UK as in the US.

Trump und Pfizer mit Abkommen: Günstigere Medikamente im Direktverkauf
Neue Zürcher Zeitung·SwitzerlandSwitzerland· 2025-10-01
6.0

Bristol Myers Squibb is included in the list of American companies announcing major investments in the U.S.

Sanofi promet d’investir 20 milliards de dollars aux Etats-Unis
Le Monde·FranceFrance· 2025-05-14
7.0